Standout Papers

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mito... 1999 2026 2008 2017 1.1k
  1. Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer (1999)
    Kiyoyuki Furuse, Masahiro Fukuoka et al. Journal of Clinical Oncology

Immediate Impact

7 from Science/Nature 58 standout
Sub-graph 1 of 20

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
Rational Design of Biomaterials to Potentiate Cancer Thermal Therapy
2023 Standout
2 intermediate papers

Works of H Nishikawa being referenced

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
1999 Standout
[Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)].
1996

Author Peers

Author Last Decade Papers Cites
H Nishikawa 1193 235 708 258 42 1.8k
Gail Walker 727 399 311 262 49 1.7k
Sang‐Hue Yen 303 348 501 120 50 1.7k
Bernhard Walter 855 508 343 136 47 2.0k
Michael E. Ray 933 224 439 372 35 1.8k
L.Steven Carpenter 773 393 177 595 45 1.8k
John E. Byfield 310 357 596 36 58 1.4k
Michèle Tarayre 1771 102 1398 300 52 2.8k
R.H. Mole 514 157 719 83 49 1.9k
Danielle M. Hari 389 309 760 18 41 2.3k
Mark L. Levitt 460 214 1104 21 43 1.9k

All Works

Loading papers...

Rankless by CCL
2026